875340-50-4 Usage
Uses
Used in Pharmaceutical Industry:
4-chloro-6-phenyl-5H-pyrrolo[3,2-d]pyrimidine is used as a chemical intermediate for the development of new drugs. Its specific structural features make it a candidate for further research and development, potentially leading to the creation of pharmaceuticals with novel therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 4-chloro-6-phenyl-5H-pyrrolo[3,2-d]pyrimidine is utilized as a building block for the synthesis of new agrochemicals. Its potential biological activities could contribute to the development of innovative products with applications in agriculture, such as pesticides or herbicides.
It is crucial to handle 4-chloro-6-phenyl-5H-pyrrolo[3,2-d]pyrimidine with care and adhere to safety guidelines due to its potential hazards and toxic effects. Further exploration and development of 4-chloro-6-phenyl-5H-pyrrolo[3,2-d]pyrimidine could unlock its full potential in both the pharmaceutical and agrochemical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 875340-50-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,5,3,4 and 0 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 875340-50:
(8*8)+(7*7)+(6*5)+(5*3)+(4*4)+(3*0)+(2*5)+(1*0)=184
184 % 10 = 4
So 875340-50-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H8ClN3/c13-12-11-10(14-7-15-12)6-9(16-11)8-4-2-1-3-5-8/h1-7,16H
875340-50-4Relevant academic research and scientific papers
INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALING
-
Page/Page column 195-196, (2010/02/15)
The invention relates to the inhibition of vascular endothelial growth factor (VEGF) receptor signaling and hepatocyte growth factor (HGF) receptor signaling. The invention provides compounds and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions